Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(S)-2-(ethoxy-d5)-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Repaglinide-d5 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Repaglinide-d5 usage and description
Repaglinide D5 is a stable isotope-labeled analog of the anti-diabetic drug repaglinide, which is used to treat type 2 diabetes. It belongs to the class of medications known as meglitinides, which stimulate insulin secretion from the pancreas in response to food intake. Repaglinide D5 contains five deuterium atoms in the molecular structure, which allows for accurate quantitative analysis in biological samples using mass spectrometry-based techniques.
The recommended dosage of repaglinide D5 is the same as that of repaglinide, which varies depending on individual patient needs and response. It is typically taken orally before meals to control blood glucose levels. As with any medication, it is important to follow the instructions provided by a healthcare professional and not to exceed the recommended dosage.
The chemical formula of repaglinide D5 is C27H28D5NO4, and its molecular weight is 449.62 g/mol. It has a melting point of 138-140°C and is soluble in organic solvents such as methanol, ethanol, and acetonitrile. The drug works by binding to ATP-sensitive potassium channels on the surface of pancreatic beta cells, which leads to an influx of calcium ions and subsequent insulin release. It has a relatively short half-life of about 1 hour and is metabolized by the liver and excreted in the urine and feces. Repaglinide D5 is generally well-tolerated, but it may cause side effects such as hypoglycemia, headache, and nausea.
